DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Peritoneal Neoplasms D010534 16 associated lipids
Peritonitis D010538 38 associated lipids
Pneumonia D011014 10 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Precancerous Conditions D011230 48 associated lipids
Pregnancy Complications D011248 19 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Proteinuria D011507 30 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Psoriasis D011565 47 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pulmonary Valve Stenosis D011666 1 associated lipids
Refsum Disease D012035 19 associated lipids
Retinal Detachment D012163 10 associated lipids
Retinitis Pigmentosa D012174 6 associated lipids
Retinoblastoma D012175 12 associated lipids
Seizures D012640 87 associated lipids
Shock D012769 11 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Mocking RJ et al. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. 2013 Psychoneuroendocrinology pmid:23465556
Mitsuhashi N and Kato J Modulation of steroid hormone receptors in the brain--inhibitory effect of fatty acids on the binding between cytosol progestin receptors in the rat cortex and R5020. 1987 Psychoneuroendocrinology pmid:2955444
Rees AM et al. Omega-3 deficiency associated with perinatal depression: case control study. 2009 Psychiatry Res pmid:19268372
Parker GB et al. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. 2006 Psychiatry Res pmid:16499974
Lucas M et al. Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). 2009 Psychiatry Res pmid:19394089
Kale A et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. 2010 Psychiatry Res pmid:19969375
Buydens-Branchey L and Branchey M Long-chain n-3 polyunsaturated fatty acids decrease feelings of anger in substance abusers. 2008 Psychiatry Res pmid:17900705
McNamara RK et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. 2008 Psychiatry Res pmid:18715653
Conklin SM et al. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. 2007 Psychiatry Res pmid:17383013
Mischoulon D and Freeman MP Omega-3 fatty acids in psychiatry. 2013 Psychiatr. Clin. North Am. pmid:23538073
Nadalin S et al. Niacin skin flush test: a research tool for studying schizophrenia. 2010 Psychiatr Danub pmid:20305586
Buretić-Tomljanović A et al. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. 2008 Psychiatr Danub pmid:18827766
Shaikh IA et al. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. 2008 Prostate pmid:18668525
Cavazos DA et al. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. 2011 Prostate pmid:21360560
Westphal C et al. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? 2011 Prostaglandins Other Lipid Mediat. pmid:21945326
Weylandt KH et al. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. 2012 Prostaglandins Other Lipid Mediat. pmid:22326554
Giudetti AM and Cagnazzo R Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases. 2012 Prostaglandins Other Lipid Mediat. pmid:23064030
Kim HY et al. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. 2011 Prostaglandins Other Lipid Mediat. pmid:21810478
Recchiuti A Resolvin D1 and its GPCRs in resolution circuits of inflammation. 2013 Prostaglandins Other Lipid Mediat. pmid:23500003
Gladyshev MI et al. Production of EPA and DHA in aquatic ecosystems and their transfer to the land. 2013 Prostaglandins Other Lipid Mediat. pmid:23500063
Serhan CN et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. 2004 Prostaglandins Other Lipid Mediat. pmid:15290791
Wagner K et al. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. 2011 Prostaglandins Other Lipid Mediat. pmid:21854866
von Schacky C The Omega-3 Index as a risk factor for cardiovascular diseases. 2011 Prostaglandins Other Lipid Mediat. pmid:21726658
Monia ZA et al. Docosahexaenoic acid reduces both cyclic nucleotide and melatonin synthesis in rat pinealocytes. 1998 Prostaglandins Other Lipid Mediat. pmid:9653768
Rapoport SI et al. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. 2011 Prostaglandins Other Lipid Mediat. pmid:21704722
Taber DF and Jackson Roberts L Nomenclature systems for the neuroprostanes and for the neurofurans. 2005 Prostaglandins Other Lipid Mediat. pmid:16303600
Hong S et al. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis. 2005 Prostaglandins Other Lipid Mediat. pmid:16303609
Yuan J et al. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. 2010 Prostaglandins Other Lipid Mediat. pmid:20394833
Seki H et al. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. 2009 Prostaglandins Other Lipid Mediat. pmid:19737659
Hishinuma T et al. Effects of long-term supplementation of eicosapentanoic and docosahexanoic acid on the 2-, 3-series prostacyclin production by endothelial cells. 1999 Prostaglandins Other Lipid Mediat. pmid:10480487
Shi H et al. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. 2016 Prostaglandins Other Lipid Mediat. pmid:27026343
Niemoller TD and Bazan NG Docosahexaenoic acid neurolipidomics. 2010 Prostaglandins Other Lipid Mediat. pmid:19804838
Yi SH et al. A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study. 2011 Prostaglandins Leukot. Essent. Fatty Acids pmid:22000478
Smithers LG et al. Human milk fatty acids from lactating mothers of preterm infants: a study revealing wide intra- and inter-individual variation. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:20417081
Gow RV et al. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder. 2009 Feb-Mar Prostaglandins Leukot. Essent. Fatty Acids pmid:19230637
Rapoport SI and Igarashi M Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? 2009 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:19540098
Yavin E Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16839753
Saldanha LG et al. Workshop on DHA as a required nutrient: overview. 2009 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:19643589
Brenna JT and Diau GY The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. 2007 Nov-Dec Prostaglandins Leukot. Essent. Fatty Acids pmid:18023566
Ren H et al. Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16410047
Manna S et al. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats. 2008 Jul-Aug Prostaglandins Leukot. Essent. Fatty Acids pmid:18614344
Puri BK et al. A 31-phosphorus neurospectroscopy study of omega-3 long-chain polyunsaturated fatty acid intervention with eicosapentaenoic acid and docosahexaenoic acid in patients with chronic refractory epilepsy. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17761409
Barber E et al. Comparative actions of omega-3 fatty acids on in-vitro lipid droplet formation. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:24012207
Bjorgvinsdottir L et al. Inflammatory response following heart surgery and association with n-3 and n-6 long-chain polyunsaturated fatty acids in plasma and red blood cell membrane lipids. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23999253
Gibson RA et al. Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:22515943
Chechi K et al. Maternal dietary fat intake during gestation and lactation alters tissue fatty acid composition in the adult offspring of C57Bl/6 mice. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:20688254
Alnajjar A et al. Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16650969
Storck Lindholm E et al. Different fatty acid pattern in breast milk of obese compared to normal-weight mothers. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23273824
van Goor SA et al. Human milk arachidonic acid and docosahexaenoic acid contents increase following supplementation during pregnancy and lactation. 2009 Prostaglandins Leukot. Essent. Fatty Acids pmid:19118992
Louw L and Dannhauser A Keloids in rural black South Africans. Part 2: dietary fatty acid intake and total phospholipid fatty acid profile in the blood of keloid patients. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:11090250